FIRST VISIT & 8-WEEK INITIAL PROGRAM During the first appointment & dose, you will be weighed, have your body measurements taken, review best lifestyle practices and expectations while taking these treatments, and your provider will administer your first dose
This is why proper exercise, hydration, and gradual dose escalation matter during weight loss therapy
Post-prandial oxidative stress in urine The oxidative stress in urinary (Isoprostane molecules) were marked elevated in all the meal challenges (except for HC meals), in both the MHL subgroup (0.37 to 0.75, 0.57 to 0.76) and MUO subgroup (0.37 to 0.47, 0.43 to 0.46)
Weight Loss Results: What the Data Shows When it comes to shedding pounds, injectable GLP-1s deliver superior results based on extensive clinical trials: Injectable semaglutide (Wegovy ) : 15-17% average body weight loss Injectable tirzepatide (Mounjaro /Zepboun d) : Up to 22.5% average body weight loss FDA-approved oral semaglutide: 13.6-16.6% average body weight loss Compounded ODT formulations : No published clinical trial data available A real-world comparison study found that patients on injectable semaglutide lost 1.62kg more than those on FDA-approved oral semaglutide over 26 weeks, which was not significant
It enhances glucose-dependent insulin secretion (meaning it prompts insulin release primarily when blood sugar is elevated), slows gastric emptying so a meal leaves the stomach more gradually, and acts on appetite centers in the brain to promote a feeling of fullness
PlexusDx offers the Precision Peptide Genetic Testa peptide-pathway genetic analysis (not pharmacogenomic testing) that examines 14 biological pathways and 150+ genetic insights relevant to GLP-1 therapy response